Skip to main content
logo
Hindustan Zinc Limited (NSE:HINDZINC)
India flag India · Delayed Price · Currency is INR
419.95
-1.25 (-0.30%)
Aug 6, 2025, 3:30 PM IST

Checkpoint Therapeutics Revenue

In the fiscal year ending March 31, 2025, Hindustan Zinc had annual revenue of 332.24B INR with 17.48% growth. Hindustan Zinc had revenue of 75.91B in the quarter ending June 30, 2025, a decrease of -3.83%.

Revenue
332.24B
Revenue Growth
+17.48%
P/S Ratio
5.34
Revenue / Employee
95.53M
Employees
3,557
Market Cap
1,774.42B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025332.24B49.44B17.48%
Mar 31, 2024282.80B-52.27B-15.60%
Mar 31, 2023335.07B45.12B15.56%
Mar 31, 2022289.95B68.44B30.90%
Mar 31, 2021221.51B37.60B20.44%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UltraTech Cement784.12B
Asian Paints338.41B
Grasim Industries1,484.78B
Vedanta1,535.31B
Pidilite Industries131.40B
Solar Industries India75.40B
Shree Cement192.83B
Jindal Steel497.65B
Revenue Rankings

Hindustan Zinc News

More News